In the liver we failed to detect a significant effect of prednisolone pre-treatment of the BD rat to reduce hepatocyte injury as assessed by AST and ALT, we did however demonstrate a significant effect on reducing PMN infiltration and IL-6, MCP-1 and IL-1 β expression. This evidence concerns the gene CCL2 and Behcet disease.